neurobiology of pain and addiction: implications for patients with chronic pain and addictive...
TRANSCRIPT
![Page 1: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/1.jpg)
Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders
Peggy Compton, RN, PhD, FAAN
Professor and Associate DeanSchool of Nursing and Health Studies
Georgetown University
![Page 2: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/2.jpg)
“For pain is perhaps but a violent pleasure? Who could determine the point where pleasure
becomes pain, where pain is still a pleasure? –Honoré De Balzac (1799–1850)
“Pleasure and pain, though directly opposite, are yet so contrived by nature as to be constant companions; and it is a fact that the same
motions and muscles of the face are employed both laughing and crying.
Pierre Charron (1541 - 1603)
Pain Pleasure
A Continuum of Sensation
![Page 3: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/3.jpg)
Becerra L. et al. Neuron. 2001;32(5):927-946.
Neuro-anatomical overlap of pain and reward
![Page 4: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/4.jpg)
•Effects can be blocked with naloxone•Binding induces second-messenger induced changes
Opioid systems in underlie both Pain and Reward responses
Ballantyne and LaForge, 2007
![Page 5: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/5.jpg)
BALB/c (common inbred)
CXBH
(recombinant inbred)
C57
(common inbred)
CXBK
(recombinant inbred)
Pain Tolerance
1
1
1
1
Analgesic Response
2,3,4,6
2,3,5
2,4,5,6,7 2,3,5,8,9
Reinforcement/ Reward Responses
2,4 2
2,4,10 2
Opioid Receptor Binding
2 2,9
+/-2 2,9,12
1Elmer, et al. 1998. 2Elmer, et al. 1995. 3Oliverio, et al. 1997. 4Semenova, et al. 1995. 5Elmer, et al. 1993. 6Olivero & Castellano. 1974. 7Brase, et al. 1977. 8 Gwynn & Domino. 1984. 9Mogil, et al. 1996. 10Belknap, et al. 1995. 11Berrettini, et al. 1994. 12Mogil, et al. 1995. 13Petruzzi, et al. 1997, 14Gelernter, et al. 1998.
Opioid Responses by Murine Strain
![Page 6: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/6.jpg)
Pain Tolerance in Opioid and Cocaine abusers
0
30
60
90
120
150
180
cold-pressor pain tolerance (seconds)
opioid abusers
cocaine abusers
ex-opioid abusers
ex-cocaine abusers
(Compton, 1994)
![Page 7: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/7.jpg)
Pain tolerance by -opioid agonist activity
0
20
40
60
80
100
120
methadone buprenorphine control
*
(n = 18/group)
Length
of
cold
-pre
ssor
imm
ers
ion
(min
)
Compton, P et al., Drug Alcohol Depend 2001; 63:139-146.
![Page 8: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/8.jpg)
“At such times I have certainly felt it a great responsibility to say that pain, which I know is an evil, is less injurious than morphia, which may be an evil. Here experience is needed. Does morphia tend to encourage the very pain it pretends to relieve?”
“On the abuse of hypodermic injections of morphia,” Clifford Albutt, Practitioner 1870; 3:327-330.
“He is also affected by a hypersensitiveness to pain, or a morbid intolerance of any kind of distress …. He suffers. His suffering is actually great. To his astigmatic inner eye it seems even greater than it is.”
“What is the morphine disease?” Charles W. Carter Journal of Inebriety 1908;30:28-33.
Not a new observation
![Page 9: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/9.jpg)
Opioid-induced Hyperalgesia
Increased sensitivity to pain resulting from opiate administration
Pain-free murine models made tolerant to morphine have significantly decreased tolerance of pain
• Opioids, in addition to providing analgesia, set in motion anti-analgesic or hyperalgesic processes
Opioid-withdrawal hyperalgesia as an “unmasking” of underlying opioid-induced hyperalgesic state
![Page 10: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/10.jpg)
OIH in animal models
• Detectable during opioid analgesia• Dose-dependent• Increases with repeated withdrawal episodes• Intensifies with antagonist precipitated withdrawal• Gender differences• Can be detected within hours of opioid administrationLi X, et al., Brain Res Mol Brain Res 2001;86:56-62.
![Page 11: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/11.jpg)
Opioid Responses by Murine Strain
Liang DY, et al., Pharmacogenet Genomics. 2006;16(11):825-35.
C57BL/6J common inbred
- Poor baseline pain tolerance- Poor analgesia response- High opioid reinforcement
![Page 12: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/12.jpg)
Pain tolerance
Opioid-induced analgesia
Opioid-induced hyperalgesia
Adapted from: Solomon R, American Psychologist 1980; 35(8):691-712; Koob GF, et al, Neuroscience & Biobehavioral Reviews 1989;13:135-140.
Opioid-induced hyperalgesia as an Opponent Process
Opioid administration
![Page 13: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/13.jpg)
*P = 0.013**P = 0.004
***
-300
-250
-200
-150
-100
-50
0
50
100
5 Minutes 15 Minutes
Secon
ds
IM morphine IV morphine IV hydromorphone Placebo
Change in Cold-Pressor Pain Tolerance by Condition at 5 and 15 Minutes
Compton P, et al. J Pain. 2003;4(9):511-519.
![Page 14: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/14.jpg)
↑ cytokine, chemokine
+
Peripheral neuron
Central neuronMaier D, et al. , 2004 ; DeLeo JA, et al., 2004
GluGluGluGlu
GluGlu
GluGlu
NMDA-RNMDA-R
PKC
+
mu opioid-R
+ morphine
Glial cell
![Page 15: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/15.jpg)
Chronic Pain and opioid-induced hyperalgesia• Across a number of case studies, the emergence
of hyperalgesia and allodynia has been reported in patients with malignant and non-malignant pain
• Occurs large or rapidly escalating doses of morphine or fentanyl
• symptoms resolved with:
• dramatically decreasing or discontinuation of opioid
• switching to a weaker opioid
• ketamine (NMDA-antagonist) administration
![Page 16: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/16.jpg)
Opioid-induced Hyperalgesia in Chronic Pain
0
10
20
30
40
50
baseline 1 month*p < 0.01
tim
e (
s)
*
Cold-pressor pain tolerance before and after one month of opioid therapy (75mg MS) in chronic pain patients (n = 6)
Chu, Clark & Angst, 2006
![Page 17: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/17.jpg)
OIH in chronic pain patients
Pain associated with standard lidocaine injection is correlated with opioid dose and duration of opioid treatment
Cohen S, et al., Reg Anesth Pain Med 2008; 33: 199-206
VA
S p
ain
in
tensi
ty
Dose in morphine equivalents Duration on opioid therapy
![Page 18: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/18.jpg)
Chronic Pain Opioid Therapy
Improved functioning Unimproved functioning
Addictive disease
+
opioid non-responsive pain
Adapted from: Weaver & Schnoll The Clinical Journal of Pain 2002 18:S61-S69 Mitra Journal of Opioid Management 2008 4:123-130.
Psychiatric Illness
Opioid-induced hyperalgesia
Opioid-responsive pain
Absence of addiction
![Page 19: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/19.jpg)
Differential Dx Nature of pain Onset
Response to opioid
administration
Type ofprevious opioid
used
Increased pain pathology
Localized to pain site
Variable Pain improves Neither
Opioid tolerance
Localized to pain site
Gradual Pain improves Long acting
Opioid withdrawal
Diffuse, hyperalgesia
Abrupt Pain improves Short acting
Opioid-induced hyperalgesia
Diffuse, hyperalgesia
Abrupt or Gradual
Pain worsens Short acting
Pseudo-addiction
Localized to pain site
Ongoing Pain improves either
Addictive disease
Diffuse, hyperalgesia
Ongoing Pain worsens Short acting
Pain Characteristics and Opioid Analgesia responses
![Page 20: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/20.jpg)
Guidelines for clinical management of OIH
• Opioid sparing strategies
• Avoid short-acting formulations
• Avoid emergence of withdrawal
• Opioid rotation
• Use of adjuvant medications
• NMDA antagonists
• GABA agonists
• Anti-inflammatory analgesics
• Low dose opioid antagonists
![Page 21: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/21.jpg)
Gaba-agonist effects on OIH
• No overall GPN effect on pain responses by group
*p=0.02, **p =0.01
***
*
*p=0.03
•However, for abstinent subjects, significant improvements in cold-pressor pain responses noted.
(Compton et al., 2010)
![Page 22: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/22.jpg)
Does pain protect patient from addiction responses?
Under acute pain conditions:
• Significantly less morphine analgesic tolerance in pain assays
• Significantly less morphine physical withdrawal symptoms (Brown et al., 2002, Vaccarino et al., 1993)
• Significantly less opioid reward or euphoria (Zacny et al., 1996)
![Page 23: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/23.jpg)
Antagonist effect of pain on IL1-ra
Compton et al, 2012
![Page 24: Neurobiology of pain and addiction: Implications for patients with chronic pain and addictive disorders Peggy Compton, RN, PhD, FAAN Professor and Associate](https://reader035.vdocument.in/reader035/viewer/2022062407/56649e5d5503460f94b56d5b/html5/thumbnails/24.jpg)
THANK YOU!
Presenter Contact Details:
Peggy Compton RN, PhD, FAANAssociate Dean and ProfessorSchool of Nursing and Health StudiesGeorgetown University [email protected]
24